methylthio-adp has been researched along with 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate in 7 studies
Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Trials (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Recent Studies (post-2010) (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) |
---|---|---|---|---|---|
146 | 2 | 43 | 420 | 1 | 143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, SY; Müller, CE | 1 |
Barnard, EA; Burnstock, G; King, BF; Simon, J; Webb, TE | 1 |
Breittmayer, JP; Frelin, C; Gachet, C; Hechler, B; Vigne, P | 1 |
Kucher, BM; Neary, JT | 1 |
Vadakkan, KI; Wu, LJ; Zhuo, M | 1 |
Delicado, EG; Ortega, F; Pérez-Sen, R; Teresa Miras-Portugal, M | 1 |
Haas, M; Reiser, G; Shaaban, A | 1 |
1 review(s) available for methylthio-adp and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
Article | Year |
---|---|
Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.
Topics: | 2017 |
6 other study(ies) available for methylthio-adp and 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate
Article | Year |
---|---|
Characterisation of a recombinant P2Y purinoceptor.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Affinity Labels; Animals; Brain; Cell Line; Electrophysiology; Inositol Phosphates; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Recombinant Proteins; Suramin; Thionucleotides; Triazines; Uridine Triphosphate; Xenopus | 1995 |
Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Brain; Calcium; Cholera Toxin; Cyclic AMP; Endothelium, Vascular; Humans; Inhibitory Concentration 50; Jurkat Cells; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thionucleotides; Transfection | 1999 |
Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Astrocytes; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Lipopolysaccharides; Purinergic P2 Receptor Agonists; Rats; Rats, Inbred F344; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X7; Stimulation, Chemical; Thionucleotides; Tumor Necrosis Factor-alpha | 2005 |
ATP-induced chemotaxis of microglial processes requires P2Y receptor-activated initiation of outward potassium currents.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Chemotaxis; Green Fluorescent Proteins; Male; Membrane Potentials; Mice; Mice, Transgenic; Microglia; Organ Culture Techniques; Patch-Clamp Techniques; Potassium; Receptors, Purinergic P2; Thionucleotides | 2007 |
ERK1/2 activation is involved in the neuroprotective action of P2Y13 and P2X7 receptors against glutamate excitotoxicity in cerebellar granule neurons.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Cell Survival; Cells, Cultured; Cerebellum; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Gene Expression Regulation; Glutamic Acid; MAP Kinase Signaling System; Neurons; Phosphorylation; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Thionucleotides; Time Factors | 2011 |
Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; Astrocytoma; Autoimmunity; Brain; Calcium Signaling; Cell Line, Tumor; Cyclic AMP; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Polymorphism, Single Nucleotide; Protein Interaction Mapping; Purinergic Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Structure-Activity Relationship; Thionucleotides; Transfection | 2014 |